indazoles has been researched along with Hepatitis B in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, S; Choi, JW; Kim, SG; Kim, YS; Yoo, JJ | 1 |
| Gao, L; Hu, H; Wu, D; Yan, Z; Young, JAT; Zeng, J | 1 |
2 other study(ies) available for indazoles and Hepatitis B
| Article | Year |
|---|---|
Pazopanib-induced severe acute liver injury: A case report.
Topics: Bilirubin; Biopsy; Carcinoma, Renal Cell; Chemical and Drug Induced Liver Injury; Female; Hepatitis B; Humans; Indazoles; Jaundice; Kidney Neoplasms; Middle Aged; Nausea; Pyrimidines; Steroids; Sulfonamides; Tomography, X-Ray Computed; Ultrasonography; United States; Vomiting | 2021 |
Activation of the Liver X Receptor Pathway Inhibits HBV Replication in Primary Human Hepatocytes.
Topics: Antigens, Viral; Antiviral Agents; Benzoates; Benzylamines; Cells, Cultured; Cholesterol 7-alpha-Hydroxylase; DNA, Viral; Drug Evaluation, Preclinical; Gene Knockdown Techniques; Hepatitis B; Hepatitis B virus; Hepatocytes; Heterocyclic Compounds, 4 or More Rings; Humans; Hydrocarbons, Fluorinated; Indazoles; Liver; Liver X Receptors; Primary Cell Culture; RNA, Viral; Signal Transduction; Sulfonamides; Virus Replication | 2020 |